
To determine the toxicity profile, zzso zzso and maximum tolerated dose of zzso administered orally once daily for 7 days, repeated every 21 zzso 

Patients who were zzso years of age, with relapsed or zzso solid tumors, and who were able to swallow capsules were zzso The starting dose was 100 zzso zzso zzso 3) and was escalated to 130 zzso zzso zzso zzso 165 zzso zzso zzso zzso 200 zzso zzso zzso zzso and 250 zzso zzso zzso 2) in zzso of three to six zzso The maximum tolerated dose was determined from zzso zzso occurring during the first treatment zzso 

zzso children zzso age, 13 years; range, zzso zzso were zzso 23 were zzso for zzso zzso included zzso zzso zzso zzso zzso zzso zzso zzso primary brain tumors zzso zzso zzso zzso tumor zzso zzso zzso and other solid tumors zzso zzso zzso zzso zzso zzso 3 sensory and motor zzso grade 3 hypertension, and grade 3 zzso were observed in patients enrolled at the 250 zzso dose zzso The maximum tolerated dose of zzso administered daily for 7 days every 21 days was 200 zzso zzso zzso at the maximum tolerated dose included zzso fatigue, peripheral sensory zzso abdominal pain, zzso zzso zzso fever, and weight zzso zzso was minimal at the maximum tolerated zzso The median number of cycles administered is 2 zzso zzso No significant zzso cumulative zzso were zzso 

zzso is well tolerated in zzso The recommended dose for phase 2 trials in solid tumors is 200 zzso administered orally, daily for 7 days every 21 zzso This dose is zzso higher than the maximum tolerated dose in adults receiving the same dosing zzso 

